Tourmaline Bio, Inc. (TRML) โ€“ 30-Min Long Trade Setup !

22
๐Ÿ“Œ ๐Ÿš€
๐Ÿ”น Asset: Tourmaline Bio, Inc. (TRML โ€“ NASDAQ)
๐Ÿ”น Timeframe: 30-Min Chart
๐Ÿ”น Setup Type: Symmetrical Triangle Breakout

๐Ÿ“Š Trade Plan (Long Position)
โœ… Entry Zone: Above $18.27 (Breakout Confirmation)
โœ… Stop-Loss (SL): Below $17.95 (Key Support Level)

๐ŸŽฏ Take Profit Targets:
๐Ÿ“Œ TP1: $18.91 (First Resistance Level)
๐Ÿ“Œ TP2: $19.62 (Extended Bullish Move)

๐Ÿ“Š Risk-Reward Ratio Calculation
๐Ÿ“‰ Risk (SL Distance):
$18.27 - $17.95 = $0.32 risk per share

๐Ÿ“ˆ Reward to TP1:
$18.91 - $18.27 = $0.64 (1:2 R/R)

๐Ÿ“ˆ Reward to TP2:
$19.62 - $18.27 = $1.35 (1:4.22 R/R)

โœ… Higher R/R than ON Stock!

๐Ÿ” Technical Analysis & Strategy
๐Ÿ“Œ Symmetrical Triangle Breakout: Price is attempting to break above trendline resistance, signaling bullish momentum.
๐Ÿ“Œ Key Resistance at $18.91: Needs to clear this level for further upside toward TP2.
๐Ÿ“Œ Volume Confirmation Needed: Ensure above-average volume above $18.27 to validate breakout.
๐Ÿ“Œ Support at $17.95: A break below this invalidates the trade setup.

๐Ÿ“‰ Trade Execution & Risk Management
๐Ÿ“Š Volume Confirmation: Look for strong bullish volume above $18.27 before entering.
๐Ÿ“‰ Trailing Stop Strategy: Move SL to entry ($18.27) after TP1 is hit.

๐Ÿ’ฐ Partial Profit Booking Strategy:
โœ” Take 50% profits at TP1 ($18.91), let the rest run toward $19.62 (TP2).
โœ” Adjust Stop-Loss to Break-even ($18.27) after TP1 is reached.

โš ๏ธ Fake Breakout Risk
โŒ If price fails to hold above $18.27, exit early.
โŒ Wait for a 30-min candle close above the breakout level before entering.

๐Ÿš€ Final Thoughts
โœ” Bullish Setup โ€“ Strong breakout potential.
โœ” Momentum Shift Possible โ€“ Watch for volume confirmation.
โœ” Best Risk-Reward Ratio (1:4.22 to TP2)!

๐Ÿ’ก Stick to the plan, manage risk, and trade smart! ๐Ÿš€๐Ÿ“ˆ
๐Ÿ”— #TRML #NASDAQ #SwingTrading #TradingView #ProfittoPath ๐Ÿ’ฐ๐Ÿ“Š

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.